| 127 | 13 | 15 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:观察分析维生素B12联合二甲双胍治疗2型糖尿病对同型半胱氨酸(Homocysteine)的影响。方法:选择2014年4月~2014年10月在河北省保定市第一医院治疗的92例2型糖尿病患者进行研究。将所有患者随机分为对照组(46例)和观察组(46例)。对照组给予二甲双胍进行治疗;观察组给予维生素B12联合二甲双胍进行治疗。最后统计分析两组的治疗效果,以及治疗前、后的维生素B12和同型半胱氨酸水平。结果:治疗1、6个月和1年后,观察组维生素B12水平明显高于对照组,差异有统计学意义(P<0.05);对照组同型半胱氨酸水平明显高于观察组,差异有统计学意义(P<0.01)。结论:维生素B12联合二甲双胍对2型糖尿病患者进行治疗,可以显著控制患者体内同型半胱氨酸的增加,同时治疗效果明显,值得推广。
Abstract：Objective:To observe and analyze the therapeutic effects of Vitamin B12 combined with metformin on type 2 diabetes patients and influence on homocysteine level.Methods:A total of 92 cases of type 2diabetes were selected in the First Hospital of Baoding for treatment from October 2014 to April 2014 were selected and randomly divided into control group(46cases)and observation group(46cases).Patients were treated by metformin in control group.Patients were treated by Vitamin B12 combined with metformin in observation group.Finally,patient outcomes,as well as Vitamin B12 and homocysteine in patients before and after treatment were analyzed.Results:Vitamin B12 levels of observation group were significantly higher than control group 1month,6months,and 1year after treatment(P<0.05).Homocysteine levels of control group were significantly higher than observation group when patients were treated after 1month,6months,and 1year(P<0.05).Conclusion:Vitamin B12 combined with metformin in type 2 diabetes treatment,can significantly inhibit increase of homocysteine showing great effects on this disease,and it's worthy of application in large scale.
1孙爱丽,刘元涛,倪一虹,等.维生素B12与甲基丙二酸水平在糖尿病二甲双胍治疗中的变化[J].中华内分泌代谢杂志,2013,29(1):24-25.
2 毛艳华,李明娥,马慧,等.老年2型糖尿病合并轻度认知功能障碍患者的药物干预研究[J].中华老年心脑血管病杂志,2015,17(3):242-245.
3 赵弋于,戴诗敏,梁世峰,等.叶酸、维生素B12与高同型半胱氨酸血症及2型糖尿病肾病的相关性[J].中国老年学杂志,2011,31(6):1032-1034.
4 段磊,石蕾,沈黎玮,等.老年人维生素B12缺乏症的临床分析[J].中国老年学杂志,2012,32(13):2704-2706.
5 Bukhari SA,Javed S,Ali M,et al.Serum haematological and biochemical indices of oxidative stress and their relationship with DNA damage and homocysteine in Pakistani type II diabetic patients[J].Pak J Pharm Sci,2015,28(3):881-889.
6 侯沃霖,张丹丹,陆蔚,等.二甲双胍对2型糖尿病患者CA125水平的影响及其相关因素[J].中华医学杂志,2014,94(18):1380-1383.
7 戴梦昭.维格列汀联用二甲双胍治疗2型糖尿病疗效和安全性的Meta分析[J].中国全科医学,2013,16(23):2714-2717.
8 许琪,陈培贤,郭雅丽,等.初诊2型糖尿病二甲双胍血药浓度与疗效的关系[J].广东医学,2013,34(16):2575-2577.
9 李蕴潜,赵丽艳,李才,等.二甲双胍与糖尿病患者的癌症发病风险[J].现代预防医学,2014,41(5):936-938.
10 郑仲萍,于敏,郑志刚.艾塞那肽联合二甲双胍治疗口服降糖药控制不佳的超重或肥胖2型糖尿病患者临床疗效观察.河北医学,2015,21(3):404-407.
11 杨长卫,马鹏飞,张建祥.二甲双胍对2型糖尿病大血管病变的防治研究进展[J].临床误诊误治,2014,27(1):107-111.
12 蒲素.二甲双胍联合甘精胰岛素治疗晚期糖尿病肾病空腹血糖的疗效观察[J].川北医学院学报,2015,30(1):64-67.
13 胡晨,张世卿,金晓艳,等.梅连消渴胶囊联合二甲双胍对糖尿病大鼠胰岛细胞及血糖水平的影响[J].南方医科大学学报,2014,34(9):1365-1369.
14 苏宏,孙萌萌,赵跃萍,等.二甲双胍对2型糖尿病患者血浆C反应蛋白和血脂水平影响[J].临床误诊误治,2014,27(6):96-98.
15 吴标良,王民登,韦华,等.糖耐量减低者血浆同型半胱氨酸、内皮素的变化及二甲双胍的干预作用研究[J].中国全科医学,2011,14(22):2522-2524.
16 米念荣,孟超,王淑芳,等.二甲双胍对初发2型糖尿病患者同型半胱氨酸和颈动脉内膜厚度的影响[J].山东大学学报(医学版),2011,49(7):6-8,14.
17 叶润清,吴晓蔓.同型半胱氨酸和超敏C反应蛋白检测在糖尿病合并脑梗死中的价值[J].广东医学,2011,32(24):3226-3227.
18 裴丽峰,韩英,向东贤,等.老年高血压患者血浆同型半胱氨酸浓度与颈动脉内膜-中层厚度相关性的临床研究[J].中国医科大学学报,2012,41(2):166-168.
19 Bukhari SA,Naqvi SA,Nagra SA,et al.Assessing of oxidative stress related parameters in diabetes mellitus type 2:cause excessive damaging to DNA and enhanced homocysteine in diabetic patients[J].Pak J Pharm Sci 2015,28(2):483-491.
20 郭沛艳,宋淑萍,罗惠辛,等.叶酸和维生素B12对糖尿病患者同型半胱氨酸和氧化应激水平的影响[J].现代预防医学,2011,38(16):3184-3186.
21 Dworacka M,Krzyzagorska E,Iskakova S,et al.Increased circulating RANTES in type 2diabetes[J].Eur Cytokine Netw2014,25(3):46-51.
基本信息:
DOI：10.13210/j.cnki.jhmu.20151203.004
中图分类号:R587.1
引用信息:
[1]耿娜,祁辉,刘虎.维生素B_(12)联合二甲双胍治疗2型糖尿病对同型半胱氨酸的影响[J].海南医学院学报,2016,22(05):444-446.DOI:10.13210/j.cnki.jhmu.20151203.004.
基金信息:
国家自然科学基金项目(81070641)~~
2015-12-03
2015-12-03
2015-12-03